Jubilant Ingrevia Declares ₹2.50 Interim Dividend, Reports Q3 FY2024-25 Revenue at ₹1,056.71 Crore

Noida, India – January 28, 2025: Jubilant Ingrevia Limited (NSE: JUBLINGREA, BSE: 543271) has announced its Q3 FY2024-25 financial results, reporting a 9.3% year-over-year (YoY) revenue growth, and declared an interim dividend of ₹2.50 per share. The company's robust performance was driven by growth across its Specialty Chemicals, Nutrition, and Chemical Intermediates segments.

Key Financial Highlights – Q3 FY2024-25 (Consolidated)​

• Revenue from Operations: ₹1,056.71 crore (YoY growth of 9.3% from ₹966.40 crore)
• Total Income: ₹1,066.20 crore
• Profit Before Tax (PBT): ₹95.57 crore (YoY increase of 15.2%)
• Profit After Tax (PAT): ₹69.38 crore (YoY growth of 11.5% from ₹62.30 crore)
• Earnings Per Share (EPS): ₹4.39 per share.

Nine-Month Performance (April – December 2024)​

• Total Revenue: ₹3,126.35 crore (YoY growth of 2.1% from ₹3,061.36 crore)
• Profit Before Tax (PBT): ₹241.83 crore
• Profit After Tax (PAT): ₹177.12 crore
• Earnings Per Share (EPS): ₹11.20 per share.

Dividend Announcement​

• Interim Dividend Declared: ₹2.50 per share
• Record Date: February 3, 2025
• Dividend Payment Date: On or before February 26, 2025.

Segment-Wise Performance​

• Specialty Chemicals: Revenue at ₹529.25 crore (YoY growth of 30.8%)
• Nutrition & Health Solutions: Revenue at ₹189.55 crore (YoY growth of 25.1%)
• Chemical Intermediates: Revenue at ₹400.84 crore (YoY decline of 14.4%).

Strategic Developments & Key Announcements​

1. Renewable Energy Investment:
   • This is the second tranche of investment in O2 Renewable Energy XVIII Pvt Ltd, which will support solar and wind energy projects, aligning with the company's green energy initiatives.
2. Stock Options Granted:
   • 100,291 stock options granted to employees under the company's ESOP program.
3. Debt & Financial Stability:
   • Outstanding commercial papers worth ₹148 crore are listed on NSE, with redemptions due in February 2025.

Management Commentary​

Jubilant Ingrevia's Board of Directors stated:
"Our strong growth in Specialty Chemicals and Nutrition segments underscores our focus on innovation and operational efficiency. The company's investment in renewable energy and expansion in high-margin businesses will continue to drive future performance.".

Market Outlook & Investor Takeaways​

• Continued investment in sustainable energy and specialty chemicals to enhance profitability.
• Stable earnings growth with firm shareholder returns via dividends.
• The long-term strategy includes expansion in global specialty chemical markets.

Jubilant Ingrevia's solid financial performance and sustainability initiatives position it for long-term growth.